Study details
Enrolling now
Personalized Theratyping Trial
George Solomon
NCT IDNCT03587961ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
20
Study length
about 7.1 years
Ages
6+
Locations
1 site in AL
What this study is about
This trial is testing Symdeko to see if it can help people with Cystic Fibrosis. It's for adults and children, and it will last about 2 years.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Symdeko
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Respiratory